196th Meeting for the Society for Endocrinology

Programme: Wednesday 9 November 2006

Mon 7 Nov | Tues 8 Nov | Wed 9 Nov | Attended Posters

Acrobat Icon Download Programme (pdf) (138kb)


 

09.00 – 10.30 Wolfson Theatre
Symposium:
Beta cell growth: implications of Type 1 and Type 2 diabetes
    Chair: Docherty K (Aberdeen)
  DS1 The onset of Type 2 diabetes - controlling the balance between beta-cell life and death
    Rhodes C (Seattle, USA)
  DS2 Islet mitogens - role in the maintenance of b-cell mass
    Stoffel M (New York, USA)
  DS3 Beta-cell death in Type 2 diabetes: a link to Type 1 diabetes
    Donath M (Geneva, Switzerland)
  DS4 Gain and loss of function strategies for directing human embryonic stem cell differentiation
    Pedersen R (Cambridge)
10.30 – 11.00 Osler/Long Room
    Coffee
11.00 – 12.00 Wolfson Theatre
    Lecture:
    Chair: Docherty K (Aberdeen)
  DS5 Cell therapy to cure
    Amiel S (London)
12.00 – 12.30 Wolfson Theatre
    Meet the Expert:
    Chair: Johnston C (Hemel Hempstead)
    The role of the chemical pathologist in the modern management of diabetes
    Kilpatrick E (Hull)
13.00 – 14.00 Osler/Long Room
    Lunch
13.00 – 14.00 Library
    Attended Posters
14.00 – 15.30 Wolfson Theatre
        Meet the Experts: Managing the younger, lean, newly diagnosed patient
    Chair: Johnston C (Hemel Hempstead)
    The role of immunology
    Leslie D (London)
    The role of genetics
    Hattersley A (Exeter)
15.30 – 16.00 Osler/Long Room
    Tea
16.00– 17.00 Wolfson Theatre
    Debate:
'This house believes that insulin is the treatment of choice for the poorly controlled, overweight patient with Type 2 diabetes'
    Chair: Johnston C (Hemel Hempstead)
        For: Davis M (Leicester)
    Against: Scott A (Sheffield)